Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Vir Biotechnology Inc. (VIR) Misses Q1 EPS by 19c
May 4, 2023 4:50 PM EDTVir Biotechnology Inc. (NASDAQ: VIR) reported Q1 EPS of ($1.06), $0.19 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $63 million versus the consensus estimate of $51.58 million.
For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.
... More